What are the guidelines for managing sepsis, including labs and medications to order?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sepsis Management Guidelines: Labs and Medications

Antimicrobial therapy must be initiated within one hour of sepsis recognition, using broad-spectrum antibiotics that cover all likely pathogens. 1, 2

Initial Assessment and Diagnosis

Laboratory Tests

  • Obtain at least two sets of blood cultures (both aerobic and anaerobic bottles) before starting antimicrobial therapy, as long as this doesn't delay treatment >45 minutes 1, 2
  • Measure serum lactate levels as a marker of tissue hypoperfusion 1
  • Consider 1,3-β-D-glucan assay, mannan, and anti-mannan antibody assays if invasive candidiasis is suspected 1
  • Obtain appropriate cultures from suspected infection sites (urine, respiratory, wound, etc.) 2
  • Complete blood count, comprehensive metabolic panel, coagulation studies, and inflammatory markers should be ordered 2

Imaging

  • Perform prompt imaging studies to identify potential sources of infection 1, 2

Antimicrobial Therapy

Initial Antimicrobial Selection

  • Administer IV antimicrobials within one hour of sepsis recognition 1, 2
  • Use broad-spectrum antibiotics that cover all likely pathogens (bacterial, potentially fungal or viral) 1
  • For septic shock, use combination therapy with at least two antibiotics of different antimicrobial classes targeting the most likely bacterial pathogens 1, 2
  • Consider the following combinations for specific scenarios:
    • Extended-spectrum β-lactam plus either aminoglycoside or fluoroquinolone for Pseudomonas aeruginosa infections 1
    • β-lactam plus macrolide for bacteremic Streptococcus pneumoniae infections 1
    • Broader coverage for patients with neutropenia or at high risk for multidrug-resistant pathogens 1

Antimicrobial Management

  • Reassess antimicrobial regimen daily for potential de-escalation 1
  • Narrow therapy once pathogen identification and sensitivities are available 1
  • Do not continue empiric combination therapy for more than 3-5 days 1
  • Typical duration of therapy is 7-10 days 1
  • Consider longer courses for:
    • Slow clinical response
    • Undrainable foci of infection
    • Bacteremia with Staphylococcus aureus
    • Some fungal and viral infections
    • Immunologic deficiencies including neutropenia 1

Hemodynamic Support

Fluid Resuscitation

  • Administer crystalloid fluids at 30 mL/kg for initial resuscitation in patients with sepsis-induced hypoperfusion 1, 2
  • Target a mean arterial pressure (MAP) ≥65 mmHg in patients requiring vasopressors 1, 2
  • Consider albumin when patients require substantial amounts of crystalloids 1
  • Avoid hetastarch formulations 1

Vasopressors and Inotropes

  • Norepinephrine is the first-choice vasopressor 1
  • Add epinephrine when an additional agent is needed to maintain adequate blood pressure 1
  • Consider vasopressin (0.03 U/min) to either raise MAP or decrease norepinephrine dose 1
  • Use dobutamine in patients with persistent hypoperfusion despite adequate fluid loading and vasopressors 1
  • Place an arterial catheter as soon as practical in patients requiring vasopressors 1

Source Control

  • Implement source control interventions as soon as possible after diagnosis 1
  • Remove intravascular access devices confirmed to be the source of sepsis after establishing alternative vascular access 1

Additional Management Considerations

  • Target hemoglobin of 7-9 g/dL in the absence of tissue hypoperfusion, ischemic coronary artery disease, or acute hemorrhage 1
  • Use low tidal volume ventilation (6 mL/kg predicted body weight) for patients with sepsis-induced ARDS 1
  • Maintain blood glucose ≤180 mg/dL using a protocolized approach 1, 2
  • Provide deep vein thrombosis prophylaxis 1
  • Use stress ulcer prophylaxis in patients with bleeding risk factors 1
  • Elevate head of bed to 30-45 degrees in mechanically ventilated patients 1, 2

Common Pitfalls and Caveats

  • Delays in antimicrobial administration significantly increase mortality - establish processes to ensure rapid delivery 1, 3
  • Failure to obtain appropriate cultures before starting antibiotics can hinder pathogen identification 1, 2
  • Inadequate source control is a common reason for persistent sepsis 1
  • Inappropriate or prolonged broad-spectrum antibiotic use contributes to antimicrobial resistance 3, 4
  • Underestimating fluid requirements or overaggressive fluid administration can both be detrimental 1, 2
  • Failure to reassess and de-escalate antimicrobial therapy when appropriate 1, 3

Remember that sepsis is a medical emergency requiring immediate intervention. The most critical elements are rapid antimicrobial administration, appropriate fluid resuscitation, source control, and ongoing reassessment of therapy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Sepsis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An approach to antibiotic treatment in patients with sepsis.

Journal of thoracic disease, 2020

Research

Empiric Antibiotics for Sepsis.

Surgical infections, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.